Innovent Biologics, Inc. (IVBXF)
OTCMKTS
· Delayed Price · Currency is USD
9.50
+1.25 (15.15%)
Jun 5, 2025, 2:44 PM EDT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $15.40 billion as of June 9, 2025. Its market cap has increased by 87.15% in one year.
Market Cap
15.40B
Enterprise Value
14.71B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$9.50
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 15.40B, an increase of 551.27%. That is a compound annual growth rate of 32.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.66B |
| Veradigm | 747.25M |
| Nika Pharmaceuticals | 666.65M |
| Tian'an Technology Group | 637.25M |
| Elite Pharmaceuticals | 619.60M |
| Glass House Brands | 443.99M |
| CytoDyn | 437.04M |
| Northwest Biotherapeutics | 391.68M |